Taken together, the RNA sequencing data, the target gene prediction analysis, and the reporter assay results suggested that ITGB1 is one of the best candidate target genes regulated by miR-134 in EBV-associated NPC cells. The gene discussed is ITGB1; the disease is nasopharyngeal carcinoma.